Show Summary Details
Page of

(p. 507) Combination Pharmacotherapy and Psychotherapy for the Treatment of Major Depressive and Anxiety Disorders 

(p. 507) Combination Pharmacotherapy and Psychotherapy for the Treatment of Major Depressive and Anxiety Disorders
Chapter:
(p. 507) Combination Pharmacotherapy and Psychotherapy for the Treatment of Major Depressive and Anxiety Disorders
Author(s):

Cindy J. Aaronson

, Gary Katzman

, and Rachel L. Moster

DOI:
10.1093/med:psych/9780199342211.003.0016
Page of

date: 23 October 2019

Clinical wisdom and intuition suggest that when treating major depression and/or anxiety disorders, combining two documented efficacious treatments such as antidepressants and psychotherapy would improve outcome. However, the data do not completely support this conclusion. This chapter reviews randomized clinical trials comparing combined pharmacotherapy and psychotherapy with monotherapy for the treatment of major depressive disorder, panic disorder, obsessive-compulsive disorder, posttraumatic stress disorder, generalized anxiety disorder, and social anxiety disorder in adults. Although DSM-V no longer categorizes posttraumatic stress disorder and obsessive-compulsive disorder as anxiety disorders, the authors continue to include them in this chapter.

Access to the complete content on Oxford Clinical Psychology requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.